Tenofovir vs. Entecavir after treatment for HBV-associated HCC

Published Date: 08 Mar 2023

This review compared the effectiveness of entecavir and tenofovir in reducing relapses and mortality after treatment for HBV-related hepatocellular carcinoma.

Read Full News

Latest News


Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Weight loss trial reports success for breast cancer patients at one year mark

2.

Lesser-known lobular breast cancer on the rise in U.S. women

3.

Guideline on management of early-stage non-small cell lung cancer released

4.

Medical Journal March 29, 2023

5.

For MDS-Related Anemia, Telomerase Inhibitor Approved.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot